Results 261 to 270 of about 1,251,100 (314)
Prostanoid signaling in retinal vascular diseases. [PDF]
Stark AK, Penn JS.
europepmc +1 more source
CompaRative Safety Analysis of Innovator and BioSimilar Ranibizumab in Chorioretinal Vascular Diseases - The CRsIBS Study. [PDF]
Chakraborty D +10 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Vascular Disease of the Spleen
Seminars in Ultrasound, CT and MRI, 2007A wide range of vascular disorders can affect the spleen. Although clinical presentation is often nonspecific, early diagnosis and treatment are mandatory in most conditions. Noninvasive imaging techniques are well suited to meet these objectives. Familiarity with normal macroscopic and microscopic vascular anatomy is a prerequisite to understand the ...
Vanhoenacker, F.M. +5 more
openaire +3 more sources
Comprehensive Physiology, 2011
Abstract Diseases of the pulmonary vasculature are a cause of increased pulmonary vascular resistance (PVR) in pulmonary embolism, chronic thromboembolic pulmonary hypertension (CTEPH), and pulmonary arterial hypertension or decreased PVR in pulmonary arteriovenous malformations on hereditary hemorrhagic ...
Melot, Christian, Naeije, Robert
openaire +5 more sources
Abstract Diseases of the pulmonary vasculature are a cause of increased pulmonary vascular resistance (PVR) in pulmonary embolism, chronic thromboembolic pulmonary hypertension (CTEPH), and pulmonary arterial hypertension or decreased PVR in pulmonary arteriovenous malformations on hereditary hemorrhagic ...
Melot, Christian, Naeije, Robert
openaire +5 more sources
Rheopheresis in Vascular Diseases
The International Journal of Artificial Organs, 2007Background Endothelial dysfunction is a common condition in many microvascular diseases, such as Age-related Macular Degeneration (AMD) and Peripheral Arterial Occlusive Disease (PAOD). Rheopheresis therapy improves ematic viscosity, shear stress and endothelial function while decreasing fibrinogen, LDL ...
Ferrannini, M +8 more
openaire +3 more sources
Rheopheresis in vascular diseases [PDF]
Rheopheresis is an extracorporal selective double-filtration procedure. In the first part of the treatment the blood is passes through the plasma filter, which separates blood cells from the plasma. Then the plasma flow to a second filter called MONET (Membranefiltration Optimised Novel Extracorporal Treatment).
Vass, Melinda +7 more
openaire +2 more sources
2016
The child presenting with possible sentinel transient ischemic event or stroke requires prompt diagnosis so that strategies to limit injury and prevent recurrent stroke can be instituted. Cerebral arteriopathy is a potent risk factor for arterial ischemic stroke in childhood.
Catherine, Amlie-Lefond, Dennis, Shaw
openaire +2 more sources
The child presenting with possible sentinel transient ischemic event or stroke requires prompt diagnosis so that strategies to limit injury and prevent recurrent stroke can be instituted. Cerebral arteriopathy is a potent risk factor for arterial ischemic stroke in childhood.
Catherine, Amlie-Lefond, Dennis, Shaw
openaire +2 more sources
RAGE, vascular tone and vascular disease
Pharmacology & Therapeutics, 2009Evidence provided by both clinical and pre-clinical studies regarding a central involvement of the receptor for advanced glycation endproducts (RAGE) in vascular disease continues to mount. RAGE is upregulated as a consequence of activation of the ubiquitous pro-inflammatory transcription factor NF-kappaB which is activated in response to diverse ...
David G S, Farmer, Simon, Kennedy
openaire +2 more sources
Current Opinion in Ophthalmology, 1995
This last year has been a particularly busy one in the field of neuro-ophthalmology. The publication of the second, important, randomized multicentered trial in neuro-ophthalmology highlights the power of randomized trials to answer important clinical questions.
openaire +2 more sources
This last year has been a particularly busy one in the field of neuro-ophthalmology. The publication of the second, important, randomized multicentered trial in neuro-ophthalmology highlights the power of randomized trials to answer important clinical questions.
openaire +2 more sources

